Source: MarketScreener

Entasis: Shareholder Alert: Ademi LLP investigates whether Entasis Therapeutics Holdings Inc. has obtained a Fair Price in its transaction with Innoviva

(marketscreener.com) MILWAUKEE, May 24, 2022 /PRNewswire/ -- Ademi LLP is investigating Entasis for possible breaches of fiduciary duty and other violations of law in its transaction with Innoviva. Click here to learn how to join the...https://www.marketscreener.com/quote/stock/ENTASIS-THERAPEUTICS-HOLD-46353304/news/Shareholder-Alert-Ademi-LLP-investigates-whether-Entasis-Therapeutics-Holdings-Inc-has-obtained-a-40531421/?utm_medium=RSS&utm_content=20220524

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Manos Perros's photo - President & CEO of Entasis

President & CEO

Manos Perros

CEO Approval Rating

88/100

Read more